000			01494 a2200373 4500
005			20250515175727.0
264		0	_c20090827
008			200908s 0 0 spa d
022			_a0213-005X
024	7		_a10.1016/s0213-005x(08)76606-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aLópez Aldeguer, José
245	0	0	_a[Lopinavir/ritonavir monotherapy. Possible indications]. _h[electronic resource]
260			_bEnfermedades infecciosas y microbiologia clinica _cDec 2008
300			_a21-3 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aClinical Trials as Topic _xstatistics & numerical data
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDrug Combinations
650	0	4	_aHIV _xdrug effects
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Protease Inhibitors _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aLopinavir
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aPyrimidinones _xadministration & dosage
650	0	4	_aRandomized Controlled Trials as Topic _xstatistics & numerical data
650	0	4	_aRitonavir _xadministration & dosage
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
650	0	4	_aVirus Replication _xdrug effects
773	0		_tEnfermedades infecciosas y microbiologia clinica _gvol. 26 Suppl 16 _gp. 21-3
856	4	0	_uhttps://doi.org/10.1016/s0213-005x(08)76606-0 _zAvailable from publisher's website
999			_c18988657 _d18988657